CN102579700A - 一种治疗关节炎的药酒 - Google Patents
一种治疗关节炎的药酒 Download PDFInfo
- Publication number
- CN102579700A CN102579700A CN2012100530545A CN201210053054A CN102579700A CN 102579700 A CN102579700 A CN 102579700A CN 2012100530545 A CN2012100530545 A CN 2012100530545A CN 201210053054 A CN201210053054 A CN 201210053054A CN 102579700 A CN102579700 A CN 102579700A
- Authority
- CN
- China
- Prior art keywords
- medicinal liquor
- glucosamine
- wine
- arthritis
- chondroitin sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010003246 arthritis Diseases 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 39
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 24
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 24
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims abstract description 22
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960002442 glucosamine Drugs 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000014101 wine Nutrition 0.000 claims description 60
- 210000000582 semen Anatomy 0.000 claims description 37
- 244000241872 Lycium chinense Species 0.000 claims description 27
- 235000015468 Lycium chinense Nutrition 0.000 claims description 27
- 235000009392 Vitis Nutrition 0.000 claims description 18
- 241000219095 Vitis Species 0.000 claims description 18
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000008482 osteoarthritis Diseases 0.000 abstract description 8
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 4
- 210000005067 joint tissue Anatomy 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241001107116 Castanospermum australe Species 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- 235000021279 black bean Nutrition 0.000 abstract 2
- 235000002532 grape seed extract Nutrition 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 238000009423 ventilation Methods 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 201000010099 disease Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical group O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210053054.5A CN102579700B (zh) | 2012-03-02 | 2012-03-02 | 一种治疗关节炎的药酒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210053054.5A CN102579700B (zh) | 2012-03-02 | 2012-03-02 | 一种治疗关节炎的药酒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579700A true CN102579700A (zh) | 2012-07-18 |
CN102579700B CN102579700B (zh) | 2014-02-26 |
Family
ID=46469302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210053054.5A Active CN102579700B (zh) | 2012-03-02 | 2012-03-02 | 一种治疗关节炎的药酒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579700B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105168874A (zh) * | 2015-08-27 | 2015-12-23 | 廖国荣 | 一种黄精药酒及其制备方法 |
CN105725190A (zh) * | 2016-02-15 | 2016-07-06 | 北京东方兴企食品工业技术有限公司 | 一种关节改善的功能性营养食品 |
CN112375633A (zh) * | 2020-11-26 | 2021-02-19 | 江苏双林海洋生物药业有限公司 | 一种氨基葡萄糖酒及其制造方法 |
CN112662500A (zh) * | 2021-01-25 | 2021-04-16 | 山西省农业科学院果树研究所 | 一种枣酒生产制备方法及蒸发器 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757339A (zh) * | 2008-10-20 | 2010-06-30 | 刘新光 | 一种治疗类风湿性关节炎的外涂内服中药 |
CN102138961A (zh) * | 2010-02-02 | 2011-08-03 | 北京绿色金可生物技术股份有限公司 | 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用 |
-
2012
- 2012-03-02 CN CN201210053054.5A patent/CN102579700B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757339A (zh) * | 2008-10-20 | 2010-06-30 | 刘新光 | 一种治疗类风湿性关节炎的外涂内服中药 |
CN102138961A (zh) * | 2010-02-02 | 2011-08-03 | 北京绿色金可生物技术股份有限公司 | 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用 |
Non-Patent Citations (3)
Title |
---|
傅欣等: "氨基葡萄糖和硫酸软骨素联合用药对兔骨关节炎治疗作用实验研究", 《中国运动医学杂志》 * |
刘丽萍等: "葡萄籽原花青素的功能及提取工艺", 《食品与药品》 * |
夏明忠: "中国大豆食疗的历史发展和疗效特点", 《西昌农业高等专科学校学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105168874A (zh) * | 2015-08-27 | 2015-12-23 | 廖国荣 | 一种黄精药酒及其制备方法 |
CN105725190A (zh) * | 2016-02-15 | 2016-07-06 | 北京东方兴企食品工业技术有限公司 | 一种关节改善的功能性营养食品 |
CN105725190B (zh) * | 2016-02-15 | 2018-09-25 | 北京东方兴企食品工业技术有限公司 | 一种关节改善的功能性营养食品 |
CN112375633A (zh) * | 2020-11-26 | 2021-02-19 | 江苏双林海洋生物药业有限公司 | 一种氨基葡萄糖酒及其制造方法 |
CN112662500A (zh) * | 2021-01-25 | 2021-04-16 | 山西省农业科学院果树研究所 | 一种枣酒生产制备方法及蒸发器 |
Also Published As
Publication number | Publication date |
---|---|
CN102579700B (zh) | 2014-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102579700B (zh) | 一种治疗关节炎的药酒 | |
CN101181449A (zh) | 一种治疗骨质增生的药酒 | |
CN101167991A (zh) | 治疗烧烫伤的药膏 | |
CN102688363A (zh) | 一种治疗风湿类关节炎的中药 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN101181427B (zh) | 治疗牛皮癣的外用药物 | |
CN101623339A (zh) | 治疗白发的中药药物 | |
CN1294949C (zh) | 治疗性功能障碍、月经不调、不育症和增强免疫功能的中药制剂 | |
CN105434739A (zh) | 一种治疗霰粒肿的中药组合物及其制备方法 | |
CN106039258A (zh) | 用于增强免疫力的组合物及其应用 | |
CN105477619A (zh) | 一种治疗月经后期的中药组合物 | |
CN105381388A (zh) | 一种治疗胃部不适的中药组合物及其制备方法 | |
CN101549074B (zh) | 治疗乳腺增生的药物 | |
CN109331152A (zh) | 一种治疗脉管炎的中药组合物 | |
CN104826095B (zh) | 一种软骨素联产蛋白粉及其生产方法和应用 | |
CN103127295B (zh) | 一种治疗白血病的中药 | |
CN104840624A (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN109771621A (zh) | 一种治疗寒厥腹满的中药组合物 | |
CN1347728A (zh) | 治疗风湿性骨关节病的中药制剂 | |
CN102000268B (zh) | 一种治疗风湿类风湿病的中药口服制剂 | |
CN104906385A (zh) | 一种治疗腹泻的中药组合物 | |
CN104547354A (zh) | 治疗高尿酸血症的中药 | |
CN1582988A (zh) | 五子山癌痛灵中药 | |
CN104547352A (zh) | 治疗面神经麻痹的药物组合物 | |
CN103263516B (zh) | 一种治疗胆囊炎的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 272113 Caohe Town Industrial Park, Yanzhou District, Jining, Shandong Patentee after: SHANDONG HAIYU BIOLOGICAL Co.,Ltd. Address before: Cao Zhen Cao he Cun 272100 Shandong city of Jining province Yanzhou city (Jiwei Road East) Patentee before: SHANDONG HAIYU BIOTECHNOLOGY CO.,LTD. |
|
CP03 | Change of name, title or address | ||
CP01 | Change in the name or title of a patent holder |
Address after: 272113 Caohe Town Industrial Park, Yanzhou District, Jining City, Shandong Province Patentee after: Shandong Haiyu Biotechnology Co.,Ltd. Address before: 272113 Caohe Town Industrial Park, Yanzhou District, Jining City, Shandong Province Patentee before: SHANDONG HAIYU BIOLOGICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PP01 | Preservation of patent right |
Effective date of registration: 20240410 Granted publication date: 20140226 |
|
PP01 | Preservation of patent right |